tbuckley/cabot-search huggingface dataset:
Abstract 12325: Psychosocial Correlates of Hypertension Among Filipinos Living in Primarily Rural Areas of the Philippines
Authors: Elizabeth Lorenzo, Lorraine S Evangelista
Journal: Circulation (2021)

Introduction: Self-reported depression, anxiety, stress, and poor health-related quality of life (HRQoL) have all been linked to an elevated risk of hypertension (HTN), although indicators of psychosocial burden among Filipinos residing in rural parts of the Philippines are poorly defined. Methods: This cross-sectional study was conducted in the Philippines in 2017 and included a large representative sample of 1203 Filipinos (64.6 % female; 49.5 ± 17.7 years old; 16% widowed) seeking care from their barangay health clinics. Sociodemographic characteristics, health history, and psychosocial factors (depression, anxiety, stress, HRQoL) were assessed through a structured survey. In addition, height, weight, blood pressure, and waist circumference were measured. Multivariable-adjusted binary logistic regression was used to assess the independent predictors of hypertension. Results: HTN was observed in 42.5%, while depression, anxiety, stress, and overweight/obesity were noted in 20.6%, 39.0%, 82.1% and 29.4%, respectively. Women were more likely to be widowed and men married. No gender differences were noted in HTN, depression, or physical HRQoL, but women were more likely to be stressed and had higher anxiety and lower mental HRQoL than men. HTN was associated with higher depression and lower physical HRQoL. Significant positive correlates of HTN were being widowed and lower physical and mental HRQoL. Stress was the only correlate of HTN for men and lower physical and mental HRQoL for women. Conclusions: The results of this study are broadly consistent with prior studies from other East Asian countries. The study stresses the significance of reconsidering methods to assess both demographic and contextual characteristics in terms of psychological comorbidities in Filipinos, which could aid in identifying those at high risk for HTN. Future research should concentrate on raising knowledge of psychosocial factors and HTN in rural communities and designing interventions that target self-management of concomitant disorders. Decision-makers and policymakers must be aware of the rising trend and the socioeconomic and psychosocial drivers of HTN to limit its influence on cardiovascular disease morbidity and mortality.
D-Dimer Levels as a Prognostic Marker for Developing AKI in Those Hospitalized with COVID-19
Authors: Anjali Acharya, Tianying Li
Journal: Journal of the American Society of Nephrology (2021)

Journal of the American Society of Nephrology 32(10S):p 777, October 2021. | DOI: 10.1681/ASN.20213210S1777b
Outcomes Following Biochemical or Clinical Progression in Patients with Multiple Myeloma
Authors: Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson I Gonsalves, Rahma M Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, Shaji Kumar
Journal: Blood (2021)
COVID-ONE-hi: The One-Stop Database for COVID-19-Specific Humoral Immunity and Clinical Parameters
Authors: Zhaowei Xu, Yang Li, Qing Lei, Likun Huang, Dan-yun Lai, Shu-juan Guo, He-wei Jiang, Hongyan Hou, Yun-xiao Zheng, Xue-ning Wang, Jiaoxiang Wu, Ming-liang Ma, Bo Zhang, Hong Chen, Caizheng Yu, Jun-biao Xue, Hai-nan Zhang, Huan Qi, Siqi Yu, Mingxi Lin, Yandi Zhang, Xiaosong Lin, Zongjie Yao, Huiming Sheng, Ziyong Sun, Feng Wang, Xionglin Fan, Sheng-ce Tao
Journal: Genomics Proteomics & Bioinformatics (2021)

Abstract Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (named COVID-ONE-hi). COVID-ONE-hi is based on the data that contain the IgG/IgM responses to 24 full-length/truncated proteins corresponding to 20 of 28 known SARS-CoV-2 proteins and 199 spike protein peptides against 2360 serum samples collected from 783 COVID-19 patients. In addition, 96 clinical parameters for the 2360 serum samples and basic information for the 783 patients are integrated into the database. Furthermore, COVID-ONE-hi provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the “START” button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-hi is freely available at www.COVID-ONE.cn.
Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
Authors: Nicolas Hoertel
Journal: JAMA Network Open (2021)

Tomiko Oskotsky, MD; Ivana Marić, PhD; Alice Tang, BS; Boris Oskotsky, PhD; Ronald J. Wong, PhD; Nima Aghaeepour, PhD; Marina Sirota, PhD; David K. Stevenson, MD
Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis
Authors: Mesire Aydin, Elisabeth Dovern, Mariska M.G. Leeflang, Josu de la Fuente, Adetola A. Kassim, Bart J. Biemond, Erfan Nur
Journal: Blood (2021)
Multiple Myeloma Oligosecretory Relapse, a Non-Negligible Phenomenon. Frequency, Clinical Characteristics and Outcomes in a Single Center
Authors: Itai Zamir, Tamir Shragai, Svetlana Trestman, Tomer Ziv Baran, Efrat Luttwak, Shai Levy, Irit Avivi, Yael C Cohen
Journal: Blood (2021)
Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center
Authors: Chenyu Lin, Laura Morrison, Edwin P. Alyea, Taewoong Choi, Cristina Gasparetto, Gwynn D. Long, Richard D. Lopez, David A Rizzieri, Stefanie Sarantopoulos, Anthony D. Sung, Nelson J. Chao, Einat Galamidi-Cohen, Aurelie Schwarzbach, Mitchell E. Horwitz
Journal: Blood (2021)
Biomarker Association with Hypertension in Mild Versus Severe Sickle Cell Disease Genotypes of a Single Center Cohort, in Comparison with African Americans from the Nhanes Study
Authors: Franklin Njoku, Xu Zhang, Binal N. Shah, Faiz Ahmed Hussain, Jin Han, Robert Molokie, Roberto Machado, Santosh L. Saraf, Victor R. Gordeuk
Journal: Blood (2021)
A Phase II Study of Mini-Hyper-CVD Plus Venetoclax in Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Authors: Sangeetha Venugopal, Hagop Kantarjian, Nicholas J. Short, Philip A. Thompson, Naveen Pemmaraju, Nitin Jain, William G. Wierda, Gautam Borthakur, Guillermo Montalban-Bravo, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, Maro Ohanian, Kelly S. Chien, Jennifer Thankachan, Benjamin Nwakanme, Rebecca Garris, Elias J. Jabbour
Journal: Blood (2021)
Real-World Experience of Patients with Sickle Cell Disease Treated with Voxelotor: A Multicenter, Retrospective Study
Authors: Biree Andemariam, Maureen Achebe, E. Leila Jerome Clay, Richard A. Drachtman, Archana Sharma, Alecia C Nero, Ifeyinwa Osunkwo, Sharada Sarnaik, Modupe Idowu, Nirmish Shah, Susanna A Curtis, Caterina Minniti
Journal: Blood (2021)
Superior Overall Survival with Blinatumomab Versus Chemotherapy As Pre-Transplant Consolidation Treatment in Children with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL): Longer Follow-up (FU) of a Phase 3 Randomized Controlled Trial (RCT)
Authors: Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, Joan D Morris, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Yi Zeng, Deepali Dilip Pilankar, William N Kormany, Cornelia Eckert, Anja Moericke, Mary Sartor, Ondrej Hrusak, Christina Peters, Vaskar Saha, Luciana Vinti, Arend von Stackelberg
Journal: Blood (2021)
Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study
Authors: Ariana M. Chao, Thomas A. Wadden, Jeanne M. Clark, Kathleen M. Hayden, Marjorie J. Howard, Karen C. Johnson, Blandine Laferrère, Jeanne M. McCaffery, Rena R. Wing, Susan Z. Yanovski, Lynne E. Wagenknecht
Journal: Diabetes Care (2021)

OBJECTIVE To evaluate changes in the prevalence of depressive symptoms, loneliness, and insomnia among older adults with type 2 diabetes from 2016 to 2020 and to assess risk factors for these conditions including demographics, multimorbidity, BMI, treatment group, and pre-coronavirus 2019 (COVID-19) measure scores. RESEARCH DESIGN AND METHODS This was a prospective, observational study of participants from the Look AHEAD (Action for Health in Diabetes) cohort study. Data were from two assessments before COVID-19 (visit 1: April 2016–June 2018 and visit 2: February 2018–February 2020) and one assessment during COVID-19 (visit 3: July–December 2020). Surveys were administered to assess depressive symptoms, loneliness, and insomnia. RESULTS The study included 2829 adults (63.2% female, 60.6% White, mean [SD] age 75.6 [6.0] years). The prevalence of mild or greater depressive symptoms did not change significantly between the two pre-pandemic visits (P = 0.88) but increased significantly from pre- to during COVID-19 (19.3% at V2 to 30.4% at V3; P &amp;lt; 0.001). Higher odds of mild or greater depressive symptoms at V3 were associated with being female (adjusted odds ratio [OR] 1.4 [95% CI 1.1–1.7]), identifying as non-Hispanic White (OR 1.4 [95% CI 1.1–1.7]), having obesity (OR 1.3 [95% CI 1.0–1.5]), and reporting mild or greater depressive symptoms at V1 (OR 4.0 [95% CI 2.9–5.4]), V2 (OR 4.4 [95% CI 3.2–5.9]), or both visits (OR 13.4 [95% CI 9.7–18.4]). The prevalence of loneliness increased from 12.3% at V1 to 22.1% at V3 (P &amp;lt; 0.001), while the prevalence of insomnia remained stable across visits at 31.5–33.3%. CONCLUSIONS The prevalence of mild or greater depressive symptoms in older adults with diabetes was more than 1.6 times higher during COVID-19 than before the pandemic.
Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies
Authors: Karen Sweiss, Meredith Russell, Gregory S Calip, Ryan Nguyen, Meshaal Khan, Eshana Shah, Ronald Ng, Kaily Kurzweil, Mahir Khan, Ammarah Nadeem, Lisa Wendt, Nicole Fuchs, Elaine Trinh, Damiano Rondelli, Pritesh R Patel
Journal: Blood (2021)
Pharmacogenomic Single Nucleotide Polymorphism (SNP) Variants As Predictors of Toxicity Phenotypes in the Treatment of Acute Childhood Leukemia
Authors: Reema Kashif, Trisha Larkin, Abdelrahman H Elsayed, Nam H.K. Nguyen, Natasha Emanuel, Vivek M. Shastri, Roya Rafiee, Karna Mangrola, Biljana N. Horn, Jatinder K. Lamba
Journal: Blood (2021)
Mucosal microbiome associates with progression to gastric cancer
Authors: Chin Wen Png, Wei Jie Jonathan Lee, Shijia Joy Chua, Feng Zhu, Khay Guan Yeoh, Yongliang Zhang
Journal: Theranostics (2021)

Background & Aims: Dysbiosis is associated with gastric cancer (GC) development.However, no longitudinal study was carried out to identify key bacteria that could predict for GC progression.Here, we aimed to investigate changes in bacterial metagenome prior to GC and develop a microbiome-based predictive model to accurately classify patients at risk of GC.Methods: Bacterial 16S rDNA was sequenced from 89 gastric antral biopsies obtained from 43 participants.This study was nested in a prospective, longitudinal study, whereby study participants underwent screening gastroscopy, with further 1-2 yearly surveillance gastroscopies for at least 5 years.Putative bacterial taxonomic and functional features associated with GC carcinogenesis were identified by comparing between controls, patients with gastric intestinal metaplasia (IM) and patients with early gastric neoplasia (EGN).Results: Patients with EGN had enrichment of Proteobacteria (in particular Proteus genus) and depletion of Bacteroidetes (in particular S24-7 family) in their gastric mucosa.Sequencing identified more patients with Helicobacter pylori compared to histopathological assessment, while H. pylori was also significantly enriched in EGN.Furthermore, a total of 261 functional features, attributing to 97 KEGG pathways were differentially abundant at baseline between patients who subsequent developed EGN (n = 13/39) and those who did not.At the same time, a constellation of six microbial taxonomic features present at baseline, provided the highest classifying power for subsequent EGN (AUC = 0.82). Conclusion:Our study highlights early microbial changes associated with GC carcinogenesis, suggesting a potential role for prospective microbiome surveillance for GC.
Global Longitudinal Strain Is Superior to Ejection Fraction for Long-Term Follow-up after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Marika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, Ruri Chijiki, Miki Saeki, Yuri Hirakawa, Hidetomo Takakura, Yutaro Usui, Rina Sakai, Sakuya Matsumoto, Yu Mizutani, Akihito Kitao, Shigeki Nagao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Hiroshi Matsuoka, Hironobu Minami
Journal: Blood (2021)
Human influenza virus challenge identifies cellular correlates of protection for oral vaccination
Authors: David R McIlwain, Han Chen, Zainab Rahil, Neda Hajiakhoond Bidoki, Sizun Jiang, Zach Bjornson, Nikita S Kolhatkar, C Josefina Martinez, Brice Gaudillière, Julien Hedou, Nilanjan Mukherjee, Christian M Schürch, Angelica Trejo, Melton Affrime, Bonnie Bock, Kenneth Kim, David Liebowitz, Nima Aghaeepour, Sean N Tucker, Garry P Nolan
Journal: Cell Host & Microbe (2021)
Review Article : Estimating Cardiovascular Risk in the 21st Century: Role of Serological Markers and Imaging as new Tools for Risk Stratification
Authors: Sonia Kunstmann F, Fernanda Gaínza K, Thomas Akel O
Journal: Clinical Cardiology and Cardiovascular Interventions (2019)

Cardiovascular diseases continue to be the primary cause of death worldwide, thus making their high burden a call for adequate prevention strategies. Estimating individual risk of suffering cardiac or cerebral vascular events allows the implementation of disease-modifying measures.Risk stratification charts based on traditional risk factors (sex, age, smoking, hypercholesterolemia, diabetes mellitus and hypertension) are the most recommended methods, given their easy use, high applicability and predictive value. Nevertheless, intermediate risk patients undergoing further stratification may require additional tools, such as serological markers and imaging. This review focuses on the utility and applicability of various tools designed for cardiovascular risk assessment
Abstract 11416: The Prognostic Impact of Myocardial Fibrosis Biomarkers for Atrial Fibrillation in a Heart Failure Population
Authors: Hannes Holmes, Amra Jujic, Martin Magnusson
Journal: Circulation (2021)

Introduction: Several studies suggest that circulating biomarkers of myocardial fibrosis are associated with worse prognosis of atrial fibrillation (AF). Hypothesis: Here, we aimed to evaluate the prognostic impact of myocardial fibrosis biomarkers for atrial fibrillation in a heart failure (HF) population Methods: Three-hundred-and-twenty-one patients hospitalized for HF (mean age 75 years; 32% women) were screened for co-existing AF and a proximity extension assay including estimation of 7 proteins associated with myocardial fibrosis; Metalloproteinase inhibitor 4 (TIMP-4), Soluble interleukin 1 receptor-like 1 (ST-2), Galectin 3 (Gal-3), Growth/differentiation factor 15 (GDF-15) and Matrix metalloproteinase 2, 3 and 9 (MMP-3, MMP-3 and MMP-9 respectively). Associations between AF and proteins were cross-sectionally studied in multivariable logistic regression models. Furthermore, associations between protein plasma levels, mortality and re-hospitalization risk were analyzed using multivariable Cox regression analysis adjusted for age sex, prevalent diabetes, smoking, body mass index (BMI), systolic blood pressure (SBP) and New York heart association classification (NYHA-class). Results: One-hundred-and-ninety-seven patients (61%) had prevalent AF at hospitalization. In multivariate logistic regression models, the prevalence of atrial fibrillation was significantly associated with increased plasma levels of TIMP-4, GDF-15, ST-2, MMP-2 and MMP-9. In the fully adjusted Cox regression model, increased plasma levels of 5 proteins yielded significant associations with mortality; TIMP4 (p=0,022 HR;1,46 CI95%1,06-2,01), GDF 15 (p=0,028; HR1,29; CI95% 1,03-1,63), Gal-3 (p=0,017; HR1,64;CI95% 1,09-2,47), ST2 (p=0,002; HR;1,43; CI95%1,14-1,80) and MMP3 (p=0,011; HR;1,29; CI95% 1,06-1,58). Further, increased levels of TIMP4 was significantly associated with rehospitalization (p=0,001; HR 1,58; C95% 1,19-2,08). Conclusions: We have demonstrated that increased plasma levels of plasma proteins related to myocardial fibrosis are associated with the risk of mortality in hospitalized HF patients, independently of traditional risk factors.
Product Characteristics and Multi-Arm Clinical Trial Design for TSC-100 and TSC-101, TCR-T Cells That Target Leukemia Following Hematopoietic Cell Transplantation
Authors: Shrikanta Chattopadhyay, Christopher Malcuit, Ryo Takeuchi, Emmett Hedblom, Warren Jaworowicz, Antoine J Boudot, Hannah Bader, James Murray, Gavin Macbeath
Journal: Blood (2021)
Assessment of Discrimination, Bias, and Inclusion in a United States Hematology and Oncology Fellowship Program
Authors: Rahma M. Warsame, Gladys B. Asiedu, Ashok Kumbamu, Joselle Cook, Sharonne N. Hayes, Carrie A. Thompson, Timothy J. Hobday, Katharine A. R. Price
Journal: JAMA Network Open (2021)

<h3>Importance</h3> Medical trainees frequently experience discrimination. Understanding their experiences is essential to improving learning environments. <h3>Objective</h3> To characterize trainee experiences of discrimination and inclusion to inform graduate medical education (GME) policies. <h3>Design, Setting, and Participants</h3> This qualitative study used an anonymous telephone interview technique to gather data from hematology and oncology fellows. All current trainees and recent graduates were eligible. Interviews were conducted anonymously with interviewer and participant in separate locations and recorded and transcribed. Data were analyzed in an iterative process into major themes using a general inductive analysis approach. Demographic information was obtained via anonymous survey. Data collection and analysis were conducted from July 2018 to November 2019. <h3>Main Outcomes and Measures</h3> Emergent themes illustrating bias and inclusion in a GME program. <h3>Results</h3> Among 34 fellows and recent graduates who were approached for this study, 20 consented and 17 were interviewed. Of those interviewed, 10 were men, and the median (range) age was 32 (29-53) years. The racial and ethnic distribution included 6 Asian individuals, 2 Black individuals, 3 Hispanic individuals, 2 multiracial individuals, and 4 White individuals. All fellows reported having experienced and/or witnessed discriminatory behavior. The themes elucidated were (1) foreign fellows perceived as outsiders, (2) US citizens feeling alien at home, (3) gender role-typing, (4) perception of futility of reporting, (5) diversity and inclusion, and (6) coping strategies. The majority of reported biases were from patients. Only 1 trainee reported any incidents. Reasons for not reporting were difficulty characterizing discrimination and doubt action would occur. Participants reported that diversity of cotrainees, involvement in committees, and open discussions promoted inclusivity. <h3>Conclusions and Relevance</h3> In this study, reports of discriminatory behavior toward trainees were common. The anonymous hotline methodology cultivated a safe environment for candid discussions. These findings suggest that GME programs should assess their learning climate regarding bias and inclusivity anonymously and develop processes to support trainees.
Prediction of Complete Remission and Survival in Acute Myeloid Leukemia Using Supervised Machine Learning
Authors: Jan-Niklas Eckardt, Christoph Rollig, Michael Kramer, Sebastian Stasik, Julia-Annabell Georgi, Peter Heisig, Frank P. Kroschinsky, Johannes Schetelig, Uwe Platzbecker, Carsten Müller-Tidow, Tim Sauer, Hubert Serve, Claudia D. Baldus, Kerstin Schaefer-Eckart, Martin Kaufmann, Stefan W. Krause, Mathias Haenel, Christoph Schliemann, Maher Hanoun, Christian Thiede, Martin Bornhaeuser, Karsten Wendt, Jan Moritz Middeke
Journal: Blood (2021)
Abstract PO-094: Gα13 loss in KPC mouse model promotes well-differentiated pancreatic tumors that are susceptible to mTOR inhibition
Authors: Mario A. Shields, Christina Spaulding, Mahmoud G. Khalafalla, Thao N. D. Pham, Hidayatullah G. Munshi
Journal: Cancer Research (2021)

Abstract Gα13 transduces signals from G protein-coupled receptors. Gα13 is pro-tumorigenic in epithelial cancer cell lines, which contrasts with its tumor-suppressive function in transgenic mouse models of lymphomas. We investigated the role of Gα13 in pancreatic tumor development and progression in a transgenic mouse model. Here we show that while loss of Gα13 in pancreatic cell lines decreases tumor growth in vivo, Gα13 loss in the Kras-driven (KC) mouse model of pancreatic tumor initiation does not affect tumor development or survival. Instead, Gα13 loss in the Kras/Tp53 (KPC) transgenic mouse model of advanced pancreatic cancer promotes well-differentiated tumors with increased tumor burden and reduced survival. Mechanistically, Gα13 loss in the KPC mouse model enhances E-cadherin-mediated cell-cell junctions and mTOR signaling. Gα13-deficient pancreatic cancer cell lines derived from these mice form well-differentiated tumors, which are susceptible to mTOR inhibition with rapamycin. Importantly, human pancreatic cancers with low Gα13 expression also exhibit increased E-cadherin protein expression and mTOR signaling. This work establishes a context-dependent role of Gα13 in pancreatic tumorigenesis, demonstrating a tumor-suppressive role in transgenic mouse models of advanced pancreatic cancer. Citation Format: Mario A. Shields, Christina Spaulding, Mahmoud G. Khalafalla, Thao N. D. Pham, Hidayatullah G. Munshi. Gα13 loss in KPC mouse model promotes well-differentiated pancreatic tumors that are susceptible to mTOR inhibition [abstract]. In: Proceedings of the AACR Virtual Special Conference on Pancreatic Cancer; 2021 Sep 29-30. Philadelphia (PA): AACR; Cancer Res 2021;81(22 Suppl):Abstract nr PO-094.
Blinatumomab and Inotuzumab for the Treatment of Multiply Relapsed Acute Lymphoblastic Leukemia: A Real-Life Campus ALL Study
Authors: Mariarita Sciumè, Cristina Papayannidis, Antonio Curti, Antonella Vitale, Sabina Chiaretti, Mario Annunziata, Fabio Giglio, Prassede Salutari, Fabio Forghieri, Davide Lazzarotto, Monia Lunghi, Annalisa Imovilli, Barbara Scappini, Massimiliano Bonifacio, Michelina Dargenio, Carmela Gurrieri, Elisabetta Todisco, Marzia Defina, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Cerrano, Lidia Santoro, Enrico Barozzi, Pasquale De Roberto, Elisa Buzzatti, Chiara Sartor, Luca Baldini, Robin Foa, Nicola S Fracchiolla
Journal: Blood (2021)